CompletedNot Applicable

Telerehabilitation in People With Long COVID

Taiwan182 participantsStarted 2021-10-12

Plain-language summary

The aim of our study is to investigate the effectiveness of telerehabilitation in Post-COVID patients.

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Individuals who had been diagnosed with COVID-19 positive and whose last PCR test or rapid antigen test was negative with the following criteria: * aged between 20 to 80 years old * persistent symptoms at least 4 weeks after recovery from COVID-19 infection, including any of the following symptoms: dyspnea, fatigue, cough, headache, chest tightness, palpitations, loss of smell, anxiety, insomnia, brain fog or joint pain * able to speak and understand Mandarin * able to walk including those who need the walking aid * had mobile phones and could easily access the Internet Exclusion Criteria: * a history of chronic obstructive pulmonary disease or other respiratory diseases * a history of arrhythmia,cancer, end-stage renal disease with dialysis, being diagnosed with mental illness, recent stroke within 6 months * inability to participate because of comorbid neurological or musculoskeletal conditions that produce moderate to severe physical disability * need all day oxygen support

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Exercise Capacity: Peak Oxygen Uptake (VO2peak) From Baseline to 12 Weeks

Timeframe: Baseline, 12 weeks

Change in Exercise Capacity: Workload (Watt) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Exercise Capacity: Anaerobic Threshold (AT) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Lung Function: Forced Expiratory Volume 1 (FEV1) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Lung Function: Forced Vital Capacity (FVC) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Lung Function: FEV1/FVC % From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Ventilation/ Perfusion Abnormalities (VE/VCO2) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Trial details

NCT IDNCT05205460

SponsorTri-Service General Hospital (TSGH)

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04-30

Results submitted2024-03-26

View on ClinicalTrials.gov More COVID-19 trials

Who can participate

Age range

20 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in Exercise Capacity: Peak Oxygen Uptake (VO2peak) From Baseline to 12 Weeks

Timeframe: Baseline, 12 weeks

Change in Exercise Capacity: Workload (Watt) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Exercise Capacity: Anaerobic Threshold (AT) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Lung Function: Forced Expiratory Volume 1 (FEV1) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Lung Function: Forced Vital Capacity (FVC) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Lung Function: FEV1/FVC % From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks

Change in Ventilation/ Perfusion Abnormalities (VE/VCO2) From Baseline to 12 Weeks

Timeframe: baseline, 12 weeks